search
Back to results

Effects of Preoperative Multidisciplinary Team Meetings for High-risk, Adult, Noncardiac Surgical Patients (PREPARATION)

Primary Purpose

Interdisciplinary Communication, Postoperative Complications, Noncardiac Surgery

Status
Recruiting
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Structured preoperative multidisciplinary team meeting
Sponsored by
Rijnstate Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Interdisciplinary Communication focused on measuring multidisciplinary team meeting, preoperative, high risk surgical patients

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: 18 years of age or older; and American Society of Anesthesiology Physical Status (ASA-PS) score is 3 or more; and Clinical Frailty Scale score is 4 or more; and Patient is planned for elective or semi-elective noncardiac surgery; and As stated by the Dutch perioperative guideline: Doubt by the surgeon or anesthesiologist (or other discipline) regarding harm-benefit ratio of the surgical procedure; or Doubt if the correct measures were taken to limit the perioperative risk as much as possible; or Doubt if the patient agrees with the surgery or the anesthesiologic treatment and expected risks. Exclusion Criteria: no informed consent unable to communicate with patient (either directly or through third party) emergency surgery Proposed surgical intervention for which a structured preoperative multidisciplinary team meeting, similar to the current study intervention, already exists in this respective hospital at the start of the study

Sites / Locations

  • Stichting Jeroen Bosch ZiekenhuisRecruiting
  • Stichting Meander Medisch CentrumRecruiting
  • Stichting OLVGRecruiting
  • Gelre ZiekenhuisRecruiting
  • Stichting Albert Schweitzer ZiekenhuisRecruiting
  • Groene Hart ZiekenhuisRecruiting
  • Universitair Medisch Centrum GroningenRecruiting
  • Zuyderland Medisch CentrumRecruiting
  • Maastricht Universitair Medisch CentrumRecruiting
  • Stichting Nijmeegs Interconfessioneel Ziekenhuis Canisius WilhelminaRecruiting
  • Stichting Bravis ZiekenhuisRecruiting
  • Stichting Protestants Christelijk Ziekenhuis IkaziaRecruiting
  • Maxima Medisch CentrumRecruiting
  • Zaans Medisch CentrumRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Active Comparator

Arm Label

Preoperative care as usual

Structured preoperative multidisciplinary team meeting

Arm Description

Patients undergoing preoperative care as usual, which does not include a structured preoperative multidisciplinary team meeting (no sMDT meeting)

Patients are discussed preoperatively in a structured preoperative multidisciplinary team meeting

Outcomes

Primary Outcome Measures

Serious Adverse Events (SAEs)
Serious adverse events (SAEs), defined as: Grade 3 or more on the Clavien Dindo classification following surgical intervention, or non-operative SAEs will be graded accordingly i.e., events necessitating hospital admission, surgical intervention, single or multi-organ failure, or death.

Secondary Outcome Measures

Disability status
The disability status of the patient, measured by the 12-item WHO disability Assessment Schedule 2.0 (WHODAS 2.0). The WHODAS 2.0 results in a metric ranging from 0 to 100 ( where 0 = no disability; 100 = full disability).
Patient experienced quality of life
Quality of life of the patient assessed by the abbreviated World Health Organization Quality of Life (WHOQOL BREF). The WHOQOL BREF results in a percentage of 0 to 100. The higher the percentage (to 100), the better the quality of life of the participant.
Regret of decision
Patients regret of decision measured by a modification of the Decision Regret Scale at 3, 6 and 12 months and qualitative interviews with several patients at 6 months. The decision regret scale is a 5-item questionnaire, scoring statements 1 (strongly agree) to 5 (strongly disagree). Final scoring consists of reversing the scores of the two negatively phrased items, then taking the mean of the five items. Last, the mean is converted to a score ranging from 0 to 100 by subtracting 1 and multiplying by 25. A higher score may indicate greater patient regret about their made treatment decisions. The scale was modified by adding a question asking by whom the decision was made. This question is not part of the previously described scoring of the 5-item decision regret scale.
Societal costs measured by a patient cost questionnaire
Societal costs as measured by a cost questionnaire at baseline, 3 and 12 months, including items of the iMTA (Institute for Medical Technology Assessment) Medical Consumption Questionnaire (iMCQ) and iMTA Productivity Cost Questionnaire (iPCQ) with a recall period of 3 months.
Hospital costs as a component of societal costs
Hospital costs based on electronic medical record (EMR) patient data, as a component of societal costs. Measured at baseline (hospital costs over a period of 3 months prior to preoperative screening) and measured during 12 months follow up.
Quality-adjusted life years as a component of societal costs
Quality-adjusted life years (QALYs) measured by the EQ-5D-5L at baseline, 3 and 12 months, as a component of societal costs.
Patients' desired outcome
Patients' desired outcome will be assessed using the Outcome Prioritization Tool (OPT) at baseline (pre-operative assessment).
Survival
Survival at 30 days, 6 months, and 1 year postoperatively
Adverse events
Adverse events at 30 days, 6 months, and 1 year postoperatively
Surgical Outcome Risk Tool (SORT)
Calculating an estimate of the patients' risk of death within 30 days of an operation.
Revised Cardiac Risk Index for Pre-Operative Risk (RCRI)
The RCRI estimates patients' risk of cardiac complications after noncardiac surgery. The index is constructed by 6 items. The 6 items are scored yes (+1) or no (0), adding up to a minimum score of 0 and a maximum score of 6. The score is categorised into 4 categories (0, 1, 2, ≥3) and converted to "risk of major cardiac event (95% CI)" defined as death, myocardial infarction, or cardiac arrest at 30 days after noncardiac surgery.
American College of Surgeons Surgical Risk Calculator (ACS-NSQIP (American College of Surgeons National Surgical Quality Improvement Program))
Estimates patients' risk of postoperative complications.
Clinical Frailty Scale (CFS)
A judgement-based frailty tool that evaluates specific domains including comorbidity, function, and cognition to generate a frailty score ranging from 1 (very fit) to 9 (terminally ill).
Metabolic Equivalent of Task (MET)
Reflecting the amount of energy used by the body during physical activity.
The number of alterations in perioperative management decided by the sMDT.
The number of alterations in perioperative management decided by the sMDT (19, 20). Examples for alterations are (but not limited to) changes in; type of anaesthesia, type of surgery, planned postoperative intensive care admission, cancellation of surgery, additional medication or diagnostics.
The nature of alterations in perioperative management decided by the sMDT.
The nature of alterations in perioperative management decided by the sMDT (19, 20). Examples for alterations are (but not limited to) changes in; type of anaesthesia, type of surgery, planned postoperative intensive care admission, cancellation of surgery, additional medication or diagnostics.
The number of different medical specialties invited to participate in the sMDT meeting
The number of different medical specialties present during the sMDT meeting in order to describe the multidisciplinary attendance of the sMDT meetings.
The number of different medical specialties present during the sMDT meeting
The number of different medical specialties present during the sMDT meeting in order to describe the multidisciplinary attendance of the sMDT meetings.
The function of attending professionals at the sMDT meeting.
The function of attending professionals at the sMDT meeting in order to describe the multidisciplinary attendance of the sMDT meetings.
Number of sMDT discussions per site
Number of sMDT discussions per site

Full Information

First Posted
November 4, 2022
Last Updated
January 19, 2023
Sponsor
Rijnstate Hospital
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), University of Twente, University Medical Center Groningen, Maastricht University Medical Center, Leiden University Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT05703230
Brief Title
Effects of Preoperative Multidisciplinary Team Meetings for High-risk, Adult, Noncardiac Surgical Patients
Acronym
PREPARATION
Official Title
Is a Preoperative Multidisciplinary Team Meeting (Cost) Effective in Optimizing Noncardiac Surgical Patient Management: The PREPARATION Study
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 1, 2022 (Actual)
Primary Completion Date
April 30, 2025 (Anticipated)
Study Completion Date
October 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Rijnstate Hospital
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), University of Twente, University Medical Center Groningen, Maastricht University Medical Center, Leiden University Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The current multicenter stepped wedge randomized cluster trial study aims to assess whether implementation of preoperative multidisciplinary team (MDT) discussions is (cost)effective for high risk noncardiac surgical patients. The main questions to answer are: Primary question: Does implementation of preoperative multidisciplinary team discussions for high risk noncardiac surgical patients diminish serious adverse events as compared to care as usual at six months postoperatively or six months after multidisciplinary team discussion in case of nonsurgical treatment? Secondary questions: Does implementation of preoperative multidisciplinary team discussion for high risk noncardiac surgical patients improve disability, survival, functional outcome, quality of life and cost-effectiveness as compared to care as usual at six months postoperatively or six months after multidisciplinary team discussion in case of nonsurgical treatment? Participants will be asked to answer questionnaires at baseline, 3, 6,9 and 12 months postoperatively or post MDT discussion. Patients for whom no structured preoperative multidisciplinary discussion is installed yet (care as usual) will be compared with patients for whom a structured preoperative multidisciplinary discussion is performed (intervention). The study will be performed in hospitals that have no established preoperative MDT meeting at the start of the study.
Detailed Description
Due to the increase in life expectancy and improved care for patients suffering from a chronic disease, the number of complex patients requiring a surgical intervention is increasing. It is important to balance the potential benefits of this surgical treatment against the risk of permanent loss of functional capacity and quality of life due to complications. European and US guidelines on perioperative care all recommend preoperative multidisciplinary team meetings for high-risk noncardiac surgical patients. However, the evidence underlying a benefit of a preoperative MDT meeting is absent and recommendations are based on expert opinion. Moreover, considerable practice variation is currently present. This study will assess the efficacy of implementation of a preoperative structured multidisciplinary team (sMDT) meeting to optimize perioperative management for high risk noncardiac surgical patients. The hypothesis is that implementation of preoperative sMDT meetings for high risk noncardiac surgical patients results in less serious adverse events, is more cost-effective, and improves quality of life and functional outcome at six months, compared to preoperative care as usual (control). A preoperative structured Multidisciplinary Team (sMDT) meeting for high risk noncardiac surgical patients will be implemented in each participating center (n=14) throughout the study. In the sMDT meeting, patients' treatment plan and alternatives will be discussed by the anesthesiologist, surgical specialist and other relevant consultants or (specialized) nurses. The primary outcome is Serious adverse events (SAEs) according to the Clavien Dindo classification grade 3 or more, at 6 months following surgery or following the preoperative sMDT meeting in case of nonsurgical management. Secondary outcomes are: functional outcome (12-item WHO Disability Assessment Schedule), survival, quality of life (WHOQOL BREF), patients' regret (including interview at 6 months), societal costs (iMCQ and iPCQ, Electronic Medical Record (EMR) data, EQ5D-5L), alterations in perioperative management and sMDT performance (MDT-MOT), and facilitators and barriers (using structured interviews health care professionals). Most secondary outcomes will be assessed at baseline, 30 days, 3, 6 and 12 months. Subgroup analyses will take place for e.g. age groups (approximate quintiles), patient sex, size of hospital, intent of surgery, BMI categories (underweight, normal, overweight, obese, ≥super obese), ASA physical status, frailty, MET score, smoking behavior, alcohol use, comorbidity index score, planned postoperative destination, educational attainment, and employment status. For detailed description, see below.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Interdisciplinary Communication, Postoperative Complications, Noncardiac Surgery, Surgical Procedures, Operative, Preoperative Care, Patient Care Team, Cost-Benefit Analysis, Comorbidities and Coexisting Conditions
Keywords
multidisciplinary team meeting, preoperative, high risk surgical patients

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
cross-sectional stepped wedge cluster randomized trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Preoperative care as usual
Arm Type
No Intervention
Arm Description
Patients undergoing preoperative care as usual, which does not include a structured preoperative multidisciplinary team meeting (no sMDT meeting)
Arm Title
Structured preoperative multidisciplinary team meeting
Arm Type
Active Comparator
Arm Description
Patients are discussed preoperatively in a structured preoperative multidisciplinary team meeting
Intervention Type
Other
Intervention Name(s)
Structured preoperative multidisciplinary team meeting
Intervention Description
The intervention to be investigated is the introduction of a preoperative structured multidisciplinary team (sMDT) meeting for high risk noncardiac surgical patients, which is attended by at least the treating surgical specialist, an anesthesiologist and another medical consultant with expertise relevant for the patients comorbidities and preferences. In the preoperative sMDT meeting, at least the following questions will be discussed as recommended by the Dutch Perioperative Guideline: Is the proposed surgical intervention appropriate care for the patient? Is the risk/benefit ratio of the proposed surgical intervention acceptable for the patient? Should the patient's condition be optimized before undergoing the proposed surgical intervention?
Primary Outcome Measure Information:
Title
Serious Adverse Events (SAEs)
Description
Serious adverse events (SAEs), defined as: Grade 3 or more on the Clavien Dindo classification following surgical intervention, or non-operative SAEs will be graded accordingly i.e., events necessitating hospital admission, surgical intervention, single or multi-organ failure, or death.
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Disability status
Description
The disability status of the patient, measured by the 12-item WHO disability Assessment Schedule 2.0 (WHODAS 2.0). The WHODAS 2.0 results in a metric ranging from 0 to 100 ( where 0 = no disability; 100 = full disability).
Time Frame
12 months
Title
Patient experienced quality of life
Description
Quality of life of the patient assessed by the abbreviated World Health Organization Quality of Life (WHOQOL BREF). The WHOQOL BREF results in a percentage of 0 to 100. The higher the percentage (to 100), the better the quality of life of the participant.
Time Frame
12 months
Title
Regret of decision
Description
Patients regret of decision measured by a modification of the Decision Regret Scale at 3, 6 and 12 months and qualitative interviews with several patients at 6 months. The decision regret scale is a 5-item questionnaire, scoring statements 1 (strongly agree) to 5 (strongly disagree). Final scoring consists of reversing the scores of the two negatively phrased items, then taking the mean of the five items. Last, the mean is converted to a score ranging from 0 to 100 by subtracting 1 and multiplying by 25. A higher score may indicate greater patient regret about their made treatment decisions. The scale was modified by adding a question asking by whom the decision was made. This question is not part of the previously described scoring of the 5-item decision regret scale.
Time Frame
12 months
Title
Societal costs measured by a patient cost questionnaire
Description
Societal costs as measured by a cost questionnaire at baseline, 3 and 12 months, including items of the iMTA (Institute for Medical Technology Assessment) Medical Consumption Questionnaire (iMCQ) and iMTA Productivity Cost Questionnaire (iPCQ) with a recall period of 3 months.
Time Frame
12 months
Title
Hospital costs as a component of societal costs
Description
Hospital costs based on electronic medical record (EMR) patient data, as a component of societal costs. Measured at baseline (hospital costs over a period of 3 months prior to preoperative screening) and measured during 12 months follow up.
Time Frame
12 months
Title
Quality-adjusted life years as a component of societal costs
Description
Quality-adjusted life years (QALYs) measured by the EQ-5D-5L at baseline, 3 and 12 months, as a component of societal costs.
Time Frame
12 months
Title
Patients' desired outcome
Description
Patients' desired outcome will be assessed using the Outcome Prioritization Tool (OPT) at baseline (pre-operative assessment).
Time Frame
baseline
Title
Survival
Description
Survival at 30 days, 6 months, and 1 year postoperatively
Time Frame
30 days, 6 months, and 1 year postoperatively
Title
Adverse events
Description
Adverse events at 30 days, 6 months, and 1 year postoperatively
Time Frame
30 days, 6 months, and 1 year postoperatively
Title
Surgical Outcome Risk Tool (SORT)
Description
Calculating an estimate of the patients' risk of death within 30 days of an operation.
Time Frame
baseline
Title
Revised Cardiac Risk Index for Pre-Operative Risk (RCRI)
Description
The RCRI estimates patients' risk of cardiac complications after noncardiac surgery. The index is constructed by 6 items. The 6 items are scored yes (+1) or no (0), adding up to a minimum score of 0 and a maximum score of 6. The score is categorised into 4 categories (0, 1, 2, ≥3) and converted to "risk of major cardiac event (95% CI)" defined as death, myocardial infarction, or cardiac arrest at 30 days after noncardiac surgery.
Time Frame
baseline
Title
American College of Surgeons Surgical Risk Calculator (ACS-NSQIP (American College of Surgeons National Surgical Quality Improvement Program))
Description
Estimates patients' risk of postoperative complications.
Time Frame
baseline
Title
Clinical Frailty Scale (CFS)
Description
A judgement-based frailty tool that evaluates specific domains including comorbidity, function, and cognition to generate a frailty score ranging from 1 (very fit) to 9 (terminally ill).
Time Frame
baseline
Title
Metabolic Equivalent of Task (MET)
Description
Reflecting the amount of energy used by the body during physical activity.
Time Frame
baseline
Title
The number of alterations in perioperative management decided by the sMDT.
Description
The number of alterations in perioperative management decided by the sMDT (19, 20). Examples for alterations are (but not limited to) changes in; type of anaesthesia, type of surgery, planned postoperative intensive care admission, cancellation of surgery, additional medication or diagnostics.
Time Frame
baseline
Title
The nature of alterations in perioperative management decided by the sMDT.
Description
The nature of alterations in perioperative management decided by the sMDT (19, 20). Examples for alterations are (but not limited to) changes in; type of anaesthesia, type of surgery, planned postoperative intensive care admission, cancellation of surgery, additional medication or diagnostics.
Time Frame
baseline
Title
The number of different medical specialties invited to participate in the sMDT meeting
Description
The number of different medical specialties present during the sMDT meeting in order to describe the multidisciplinary attendance of the sMDT meetings.
Time Frame
baseline
Title
The number of different medical specialties present during the sMDT meeting
Description
The number of different medical specialties present during the sMDT meeting in order to describe the multidisciplinary attendance of the sMDT meetings.
Time Frame
baseline
Title
The function of attending professionals at the sMDT meeting.
Description
The function of attending professionals at the sMDT meeting in order to describe the multidisciplinary attendance of the sMDT meetings.
Time Frame
baseline
Title
Number of sMDT discussions per site
Description
Number of sMDT discussions per site
Time Frame
through study completion, 3 years
Other Pre-specified Outcome Measures:
Title
Performance of sMDTs using an MDT-Meeting Observational Tool (MDT-MOT)
Description
In a subset of patients: Performance of sMDTs using an MDT-Meeting Observational Tool (MDT-MOT).(21) In the MDT-MOT 10 observable teamwork domains are rated on a 5-point rating scale, using descriptive anchors for the extremes and midpoint of the scale. A score of '5' represents optimal effectiveness, calibrated against recommendations within 'The Characteristics of an Effective MDT' (by the National Cancer Action Team). A score of '3' represents effectiveness that exhibits some degree of agreement with the optimum, but not consistently, and a score of '1' represents no or little agreement with the defined optimum. Scores of '2' and '4' are included in the tool but not defined to allow observers the freedom to gradate their assessment.
Time Frame
6 months
Title
Facilitators and barriers to organize preoperative sMDT meetings
Description
Facilitators and barriers to organize preoperative sMDT meetings are evaluated using structured interviews with health care professionals from all different medical specialties.
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18 years of age or older; and American Society of Anesthesiology Physical Status (ASA-PS) score is 3 or more; and Clinical Frailty Scale score is 4 or more; and Patient is planned for elective or semi-elective noncardiac surgery; and As stated by the Dutch perioperative guideline: Doubt by the surgeon or anesthesiologist (or other discipline) regarding harm-benefit ratio of the surgical procedure; or Doubt if the correct measures were taken to limit the perioperative risk as much as possible; or Doubt if the patient agrees with the surgery or the anesthesiologic treatment and expected risks. Exclusion Criteria: no informed consent unable to communicate with patient (either directly or through third party) emergency surgery Proposed surgical intervention for which a structured preoperative multidisciplinary team meeting, similar to the current study intervention, already exists in this respective hospital at the start of the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Romijn M. Boerlage, MD
Phone
+3188 005 8833
Email
preparation@rijnstate.nl
First Name & Middle Initial & Last Name or Official Title & Degree
Rutger J. Spruit, MD
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nick J. Koning, MD PhD DESA
Organizational Affiliation
Rijnstate Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jacqueline E. Vernooij, MD, MA
Organizational Affiliation
Rijnstate Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Stichting Jeroen Bosch Ziekenhuis
City
's-Hertogenbosch
ZIP/Postal Code
5223GZ
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Manuela A di Biase, MD
Email
m.di.biase@jbz.nl
First Name & Middle Initial & Last Name & Degree
Barbe Pieters, MD, PhD
Email
b.pieters@jbz.nl
Facility Name
Stichting Meander Medisch Centrum
City
Amersfoort
ZIP/Postal Code
3817TZ
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kristy MJ Nieuwpoort, MD
Email
kmj.nieuwpoort@meandermc.nl
Facility Name
Stichting OLVG
City
Amsterdam
ZIP/Postal Code
1091
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jasper E Kal, MD, PhD
Email
J.E.Kal@olvg.nl
First Name & Middle Initial & Last Name & Degree
Bram Thiel
Email
B.Thiel@olvg.nl
First Name & Middle Initial & Last Name & Degree
Jasper Kal, MD, PhD
Facility Name
Gelre Ziekenhuis
City
Apeldoorn
ZIP/Postal Code
7334DZ
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bies Oedairadjsingh, MD
Email
b.oedairadjsingh@gelre.nl
First Name & Middle Initial & Last Name & Degree
Maaike Langelaan
Email
Maaike.Langelaan@gelre.nl
Facility Name
Stichting Albert Schweitzer Ziekenhuis
City
Dordrecht
ZIP/Postal Code
3318AT
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anika Filius, MD, PhD
Email
A.Filius@asz.nl
First Name & Middle Initial & Last Name & Degree
Petra Y Ensink
Email
p.y.ensink@asz.nl
First Name & Middle Initial & Last Name & Degree
Anika Filius, MD, PhD
First Name & Middle Initial & Last Name & Degree
Minke C Kortekaas, MD
Facility Name
Groene Hart Ziekenhuis
City
Gouda
ZIP/Postal Code
2803HH
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Koene van der Sloot, MD
Email
Koene.van.der.Sloot@ghz.nl
First Name & Middle Initial & Last Name & Degree
Amanda Ruijs, MD
Email
Amanda.Ruijs@ghz.nl
First Name & Middle Initial & Last Name & Degree
Koene van der Sloot, MD
Facility Name
Universitair Medisch Centrum Groningen
City
Groningen
ZIP/Postal Code
9713GZ
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rutger J Spruit, MD
Email
r.j.spruit@umcg.nl
First Name & Middle Initial & Last Name & Degree
Rob Spanjersberg, MSc
Email
r.spanjersberg@umcg.nl
First Name & Middle Initial & Last Name & Degree
Michel Struys, MD, PhD
First Name & Middle Initial & Last Name & Degree
Barbara L van Leeuwen, MD, PhD
Facility Name
Zuyderland Medisch Centrum
City
Heerlen
ZIP/Postal Code
6419PC
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zjuul Segers, MD
Email
z.segers@zuyderland.nl
First Name & Middle Initial & Last Name & Degree
Zjuul Segers, MD
Facility Name
Maastricht Universitair Medisch Centrum
City
Maastricht
ZIP/Postal Code
6229HX
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dianne de Korte-de Boer, MSc, PhD
Email
dianne.de.korte@mumc.nl
First Name & Middle Initial & Last Name & Degree
Lotte Grevendonk, MSc. PhD
Email
lotte.grevendonk@mumc.nl
First Name & Middle Initial & Last Name & Degree
Dianne de Korte-de Boer, MSc, Phd
First Name & Middle Initial & Last Name & Degree
Dominique Schoester, MD
Facility Name
Stichting Nijmeegs Interconfessioneel Ziekenhuis Canisius Wilhelmina
City
Nijmegen
ZIP/Postal Code
6532SZ
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Martin MJ Hagenaars, MD
Email
m.hagenaars@cwz.nl
First Name & Middle Initial & Last Name & Degree
Chu Ya Yang, MD
Email
c.yang@cwz.nl
First Name & Middle Initial & Last Name & Degree
Martin Hagenaars, MD
Facility Name
Stichting Bravis Ziekenhuis
City
Roosendaal
ZIP/Postal Code
4708AE
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Taco van den Ende, MD
Email
t.vandenende@bravis.nl
First Name & Middle Initial & Last Name & Degree
Taco van den Ende, MD
Facility Name
Stichting Protestants Christelijk Ziekenhuis Ikazia
City
Rotterdam
ZIP/Postal Code
3083AN
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marjolein CO van den Nieuwenhuyzen, MD, PhD
Email
mco.vanden.nieuwenhuyzen@ikazia.nl
Facility Name
Maxima Medisch Centrum
City
Veldhoven
ZIP/Postal Code
5504DB
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Esther M Dias, MD
Email
esther.dias@mmc.nl
First Name & Middle Initial & Last Name & Degree
Patrick Meijer, MD, Phd
Email
p.meijer@mmc.nl
First Name & Middle Initial & Last Name & Degree
Esther Dias, MD
Facility Name
Zaans Medisch Centrum
City
Zaandam
ZIP/Postal Code
1502DV
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michel Timmerman, MD
Email
timmerman.m@zaansmc.nl
First Name & Middle Initial & Last Name & Degree
Michel Timmerman, MD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Data will be made accessible on request after agreement has been received from the entire project group. The principal investigator will communicate data availability with researchers sending the requests.
IPD Sharing Time Frame
Starting 12 months after publication
IPD Sharing Access Criteria
Data will be made accessible on request after agreement has been received from the entire project group.

Learn more about this trial

Effects of Preoperative Multidisciplinary Team Meetings for High-risk, Adult, Noncardiac Surgical Patients

We'll reach out to this number within 24 hrs